Download PDF
Klin Padiatr 2012; 224(03): 170-173
DOI: 10.1055/s-0032-1308987
Case Report
© Georg Thieme Verlag KG Stuttgart · New York

Malignant Peritoneal Mesothelioma in a 16-Year-Old Girl: Presentation of a Rare Disease

Malignes peritoneales Mesotheliom bei einem 16-jährigen Mädchen: Manifestation einer seltenen Erkrankung
I. B. Brecht
1    Pediatric Hematology and Oncology, University Hospital ­Erlangen, Germany
,
A. Agaimy
2    Institute of Pathology, University Hospital Erlangen, Germany
,
M. Besendörfer
3    Pediatric Surgery, University Hospital Erlangen, Germany
,
R. Carbon
3    Pediatric Surgery, University Hospital Erlangen, Germany
,
F. C. Thiel
4    Obstetrics and Gynecology, University Hospital Erlangen, Germany
,
O. Rompel
5   Pediatric Radiology, University Hospital Erlangen, Germany
,
D. Osinski
1    Pediatric Hematology and Oncology, University Hospital ­Erlangen, Germany
,
T. Langer
1    Pediatric Hematology and Oncology, University Hospital ­Erlangen, Germany
,
M. Metzler
1    Pediatric Hematology and Oncology, University Hospital ­Erlangen, Germany
,
W. Holter
1    Pediatric Hematology and Oncology, University Hospital ­Erlangen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
18 April 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Background:

Malignant peritoneal mesothelioma is extremely rarely seen in young patients.

Patient:

A 16 year-old girl presented with appendicitis-like acute abdominal pain. Intra-operatively, multiple confluent peritoneal nodules were seen on the entire greater omentum and in the pelvis infiltrating the uterus and both ovaries. Biopsies were obtained and interpreted as serous ovarian carcinoma. Radical surgical resection and hyperthermic intraperitoneal chemotherapy ­(HIPEC) with carboplatin was performed and followed by 2 cycles of carboplatin/paclitaxel. Histological reevaluation showed characteristic features of epithelioid peritoneal mesothelioma and ruled out serous ovarian cancer. Therapy was continued with 6 cycles of pemetrexed/cisplatin.

Results:

3 months after end of chemotherapy vital tumor tissue was found in the recess behind the liver, which could be resected completely. The patient is currently disease-free 17 months after initial diagnosis.

Conclusion:

Malignant peritoneal mesothelioma in young female patients might be under-recognized and possibly misdiagnosed as ovarian serous carcinoma in some cases. International and interdisciplinary cooperation is necessary in order to provide evidence based guidelines for diagnosis and treatment in the future.

Zusammenfassung

Hintergrund:

Das maligne peritoneale Mesothe­liom wird bei jungen Patienten extrem selten beobachtet.

Patient:

Ein 16-jähriges Mädchen präsentierte sich mit appendizitisartigem akutem Bauchschmerz. Intraoperativ fanden sich konfluierende Tumormassen im gesamten Omentum und im Beckenperitoneum mit Infiltration beider Ova­rien und des Uterus. Biopsien wurden durchgeführt und diese als seröses Ovarialkarzinom interpretiert. Es wurde eine radikale chirurgische Resektion ­mit anschließender hyperthermer intraperitonealer Che­moperfusion (HIPEC) mit Carboplatin durchgeführt, gefolgt von 2 Blöcken Carboplatin/Paclitaxel. Eine histopathologische Reevaluation zeigte den cha­rakteristischen Befund eines epitheloiden malignen peritonealen Mesothelioms. Ein serö­ses Ovarialkarzinom konn­te ausgeschlossen werden. Die Therapie wurde fortgeführt mit 6 Zyklen Pemetrexed/Cisplatin.

Ergebnisse:

3 Monate nach Ende der Chemotherapie wurde vitales Tumorgewebe im Recessus hinter der Leber gefunden, welches komplett reseziert werden konnte. Die Patientin lebt derzeit rezidivfrei (17 Monate nach Primärdiagnose).

Schlussfolgerung:

Das maligne peritoneale Me­sotheliom ist bei jungen Patientinnen möglicherweise unterdiagnostiziert, einige Fälle könn­ten als seröse Karzinome fehlinterpretiert werden. Internationale und interdisziplinäre Ko­operation ist notwendig, um in Zukunft evidenzbasierte Leitlinien für Diagnose und Behandlung erstellen zu können.

Key words

malignant peritoneal mesothelioma - rare tumors - pediatric - ovarian carcinoma

Schlüsselwörter

malignes peritoneales Mesotheliom - seltene Tumoren - pädiatrisch - Ovarialkarzinom
 

  • References

  • 1 Abe Y, Tamura K, Sakata I et al. Clinical implications of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Oncol Rep 2012; 27 (02) 333-338
    PubMedGoogle Scholar
  • 2 André N, Agaimy A. In: Schneider DT, Brecht IB, Olson TA, Ferrari A. (eds.). Rare Tumors in Children and Adolescents. Springer Series: Pediatric Oncology. 1st Edition January 25th 2012
    CrossrefGoogle Scholar
  • 3 André N, Ratsimandresy R, Reguerre Y et al. Paediatric malignant mesothelioma: the SFCE experience. Pediatr Blood Cancer 2009; 53: 823
    PubMedGoogle Scholar
  • 4 Brecht IB, Graf N, Schweinitz DV et al. Networking for children and adolescents with extremely rare tumors: Foundation of the GPOH Pediatric Rare Tumor Group. Klin Padiatr May 2009; 221: 181-185
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Cioffredi LA, Jänne P, Lackman D.. Treatment of peritoneal mesothelioma in pediatric patients. Pediatr Blood Cancer 2009; 1: 127-129
    PubMedGoogle Scholar
  • 6 Kasanskiy SV, Andre N. Paediatric mésothelioma: is there such a disease?. Bull Cancer 2010; 97: 571-576
    PubMedGoogle Scholar
  • 7 Laack E, Schütte J, Dierkesmann R. Malignes Mesotheliom. Deutsche Gesellschaft für Hämatologie und Onkologie Juli 2005; http://www.dgho.de/informationen/leitlinien/solide-tumore/Mesotheliom.pdf
    PubMedGoogle Scholar
  • 8 Lawrenz B, Henes M, Neunhoeffer E et al. Fertility preservation in girls and adolescents before chemotherapy and radiation – review of the literature. Klin Padiatr May 2011; 223: 126-130
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Milano E, Pourroy B, Rome A et al. Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma. Anticancer Drugs 2006; 17: 1231-1234
    CrossrefPubMedGoogle Scholar
  • 10 Moran CA, Albores-Saavedra J, Suster S. Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology 2008; 52: 824-830
    CrossrefPubMedGoogle Scholar
  • 11 Schneider DT, Brecht IB. Care for Rare Cancers: Improved Care Requires Improved Communication. Klin Padiatr May 2010; 222: 124-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644
    CrossrefPubMedGoogle Scholar
  • 13 Yan TD, Deraco M, Baratti D et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009; 27: 6237-6242
    CrossrefPubMedGoogle Scholar